IL17A and toxoplasmosis: There are 31 intersection targets for hyperuricemia, the main targets are RELA, MAPK1, NFKBIA, CASP3, CASP8, and TNF, and the main pathways include pathways in cancer, apoptosis, hepatitis B, IL-17 signaling pathway, and toxoplasmosis.